(Q82477374)
Statements
Economic evaluation of the 21-gene signature (Oncotype DX) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03) (English)
Masahide Kondo
Shu-Ling Hoshi
Takeharu Yamanaka
Hiroshi Ishiguro
17 November 2010